Modern-day challenges in therapeutic protein production

AIDS: Modern Concepts and Therapeutic Challenges

In the rush of current publications concerning AIDS, it is difficult to distinguish between new, noteworthy articles and those of lesser significance. There is need for a compilation of up-to-date scientific information in this rapidly growing field. AIDS: Modern Concepts and Therapeutic Challenges fills that need. Edited by Samuel Broder, Associate Director of the National Cancer Institute's C...

Research Essay: Challenges and Considerations of Modern Day Portal Tooling

Java based Portals have come a long way. The inception of open portlet standards, like JSR168 and the more open JSR286, has led to their wider adoption across verticals and horizontals. Now, Java EE and non-standard MVC frameworks are becoming available for Portlet programming and part of portal applications. The design and development of portal applications is increasingly being done in the li...

Recombinant therapeutic proteins: production platforms and challenges.

Since the approval of insulin in 1982, more than 120 recombinant drug substances have been approved and become available as extremely valuable therapeutic options. Exact copying of the most common human form is no longer a value per se, as challenges, primarily related to the pharmacokinetics of artificial recombinant drugs, can be overcome by diverging from the original. However, relatively mi...

Corporate Wellness Programs: Implementation Challenges in the Modern American Workplace

Being healthy is important for living well and achieving longevity. In the business realm, furthermore, employers want healthy employees, as these workers tend to be more productive, have fewer rates of absenteeism, and use less of their health insurance resources. This article provides an overview of corporate “wellness” efforts in the American workplace and the concomitant challenges which em...

High-Risk Percutaneous Coronary Interventions in Modern Day Clinical Practice: Current Concepts and Challenges.